TMS for Anorexia
Trial Summary
What is the purpose of this trial?
This trial uses a type of brain stimulation called theta burst rTMS to treat adults with Anorexia Nervosa. The treatment targets a specific brain area involved in obsessive and compulsive behaviors. The goal is to reduce these symptoms and improve patients' eating habits. Theta burst stimulation (TBS) is a newer and more effective form of repetitive transcranial magnetic stimulation (rTMS) that has shown promise in treating neuropsychiatric disorders.
Will I have to stop taking my current medications?
No, you can continue taking your current medications as long as they have been stable for 4 weeks before the study and you agree to keep taking them throughout the study.
What data supports the effectiveness of the treatment Repetitive Transcranial Magnetic Stimulation (rTMS) for Anorexia?
Is repetitive transcranial magnetic stimulation (rTMS) safe for humans?
How is repetitive transcranial magnetic stimulation (rTMS) different from other treatments for anorexia nervosa?
Repetitive transcranial magnetic stimulation (rTMS) is unique because it is a brain-directed treatment that uses magnetic fields to stimulate specific areas of the brain, such as the dorsolateral prefrontal cortex, which may help reduce symptoms of anorexia nervosa. Unlike traditional therapies, rTMS is non-invasive and does not involve medication, making it a novel option for those with treatment-resistant anorexia or comorbid conditions like depression.13479
Research Team
Andrew M Lee, MD, PhD
Principal Investigator
University of California, San Francisco
Eligibility Criteria
This trial is for outpatients aged 18-45 with Anorexia Nervosa (AN), stable on psychotropic meds for 4 weeks, and able to give informed consent. Excluded are those with schizophrenia, bipolar disorder, severe neurocognitive disorders, seizure disorders, metal in the head or certain implanted devices.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive five treatments of inhibitory continuous theta burst rTMS to the right orbitofrontal cortex every hour over the course of 10 days
Follow-up
Participants are monitored for safety and effectiveness after treatment with assessments at 1 month and ongoing monthly evaluations for a year
Treatment Details
Interventions
- Repetitive Transcranial Magnetic Stimulation (rTMS)
Repetitive Transcranial Magnetic Stimulation (rTMS) is already approved in United States, European Union, Canada, Japan for the following indications:
- Depression
- Smoking cessation
- Depression
- Depression
- Depression
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor